FDA Grants Full Approval of Pfizer-BioNTech V...

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/ ...  Show more

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. US President Donald Trump is calling for an emergency wholesale electricity auction that, his administration says, will force technology companies to pay for the new power they need to run massive AI data cente ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

An official rollout of Covid-19 vaccine booster doses could begin within weeks, pending FDA authorization. The Biden administration has had internal conversations about scaling back the ambitious booster plan laid out by federal health officials. The Pfizer/BioNTech booster plan ...  Show more

The Food and Drug Administration has authorized a vaccine by Pfizer and BioNTech that will start reaching the most at-risk Americans today. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks through the final hurdles the vaccine had to clear over the weekend. To learn more ab ...  Show more

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  Show more